Stockscreener 앱 받기
0.3967
0.40%
0.0016
전일 마감가:
$0.3951
열려 있는:
$0.395
하루 거래량:
48,103
Relative Volume:
0.05
시가총액:
$1.61M
수익:
$1.93M
순이익/손실:
$-3.10M
주가수익비율:
-0.0242
EPS:
-16.3657
순현금흐름:
$-1.93M
1주 성능:
-3.43%
1개월 성능:
-24.84%
6개월 성능:
-59.17%
1년 성능:
-77.78%
1일 변동 폭
$0.384
$0.4018
1주일 범위
$0.368
$0.4482
52주 변동 폭
$0.30
$3.37
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
명칭
China Sxt Pharmaceuticals Inc
전화
-
주소
-
SXTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
0.3967 | 1.61M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. Announces CEO Changes -January 23, 2025 at 04:15 pm EST - Marketscreener.com
Before Buying China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock, Read This First - Stocks Register
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy? - Defense World
SXTC stock hits 52-week low at $0.36 amid sharp annual decline - Investing.com
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
SXTC stock hits 52-week low at $0.37 amid sharp annual decline - Investing.com Australia
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
China SXT Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Insider’s View: Deciphering China SXT Pharmaceuticals Inc (SXTC)’s Financial Health Through Ratios - The Dwinnex
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
How does SXTC’s price to cash per share ratio compare in the market? - US Post News
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
China's First Generic Version of AstraZeneca's Xigduo XR Diabetes Pill Gets Green Light - Yicai Global
SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES – Company A - Financial Times
China SXT Pharmaceuticals Inc (SXTC)’s results reveal risk - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock touches 52-week low at $0.6 amid sharp annual decline - Investing.com India
Closing Figures Unveiled: China SXT Pharmaceuticals Inc (SXTC) Drop -8.88, Closes at 0.63 - The Dwinnex
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com Australia
SXTC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Resilience: China SXT Pharmaceuticals Inc (SXTC) Finishes Weak at 0.94, Down -6.00 - The Dwinnex
China SXT Pharma stock hits 52-week low at $0.92 amid downturn - Investing.com India
SXTC stock hits 52-week low at $0.93 amid sharp annual decline - Investing.com India
Balance Sheet Insights: China SXT Pharmaceuticals Inc (SXTC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Successful Portfolios LLC Lowers Stock Holdings in The Southern Company (NYSE:SO) - Defense World
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals: Operational Risks and Profit Repatriation Challenges - TipRanks
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule - Yahoo Finance
China Sxt Pharmaceuticals Inc (SXTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.51%
자본화:
|
볼륨(24시간):